{"id":3790,"date":"2024-04-09T23:01:13","date_gmt":"2024-04-09T23:01:13","guid":{"rendered":"https:\/\/medexperts.pro\/?p=3790"},"modified":"2024-04-09T23:28:41","modified_gmt":"2024-04-09T23:28:41","slug":"england-limits-youth-gender-medications-part-of-big-shift-in-europe","status":"publish","type":"post","link":"https:\/\/medexperts.pro\/?p=3790","title":{"rendered":"England Limits Youth Gender Medications, Part of Big Shift in Europe"},"content":{"rendered":"
<\/div>\n

Five European countries have recently restricted hormone treatments for adolescents with gender distress. They have not banned the care, unlike many U.S. states.<\/p>\n

\n
\n
\n

The National Health Service in England started restricting gender treatments for children this month, making it the fifth European country to limit the medications because of a lack of evidence of their benefits and concern about long-term harms.<\/p>\n

England\u2019s change resulted from a four-year review released Tuesday evening by Dr. Hilary Cass, an independent pediatrician. \u201cFor most young people, a medical pathway will not be the best way to manage their gender-related distress,\u201d the report concluded. In a related editorial published in a medical journal, Dr. Cass said the evidence that youth gender treatments were beneficial was \u201cbuilt on shaky foundations.\u201d<\/p>\n

The N.H.S. will no longer offer drugs that block puberty, except for patients enrolled in clinical research. And the report recommended that hormones like testosterone and estrogen, which spur permanent physical changes, be prescribed to minors with \u201cextreme caution.\u201d (The guidelines do not apply to doctors in private practice, who serve a small fraction<\/a> of the population.)<\/p>\n

England\u2019s move is part of a broader shift in northern Europe, where health officials have been concerned by soaring demand for adolescent gender treatments in recent years. Many patients also have mental health conditions that make it difficult to pinpoint the root cause of their distress, known as dysphoria.<\/p>\n<\/div>\n<\/div>\n

<\/div>\n
\n
\n

In 2020, Finland\u2019s health agency restricted the care by recommending psychotherapy as the primary treatment for adolescents with gender dysphoria. Two years later, Sweden restricted hormone treatments to \u201cexceptional cases.\u201d<\/p>\n

In December, regional health authorities in Norway designated youth gender medicine as a \u201ctreatment under trial,\u201d meaning hormones will be prescribed only to adolescents in clinical trials. And in Denmark, new guidelines<\/a> being finalized this year will limit hormone treatments to transgender adolescents who have experienced dysphoria since early childhood.<\/p>\n

\n
\n
<\/div>\n
\n
\n
\n

We are having trouble retrieving the article content.<\/p>\n

Please enable JavaScript in your browser settings.<\/p>\n<\/div>\n<\/div>\n

\n
\n

Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into<\/a>\u00a0your Times account, or\u00a0subscribe<\/a>\u00a0for all of The Times.<\/p>\n

\n<\/div>\n
\n
\n

Thank you for your patience while we verify access.<\/p>\n

Already a subscriber?\u00a0Log in<\/a>.<\/p>\n

Want all of The Times?\u00a0Subscribe<\/a>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

Five European countries have recently restricted hormone treatments for adolescents with gender distress. They have not banned the care, unlike many U.S. states.The National Health Service in England started restricting gender treatments for children this month, making it the fifth European country to limit the medications because of a lack of evidence of their benefits and concern about long-term harms.England\u2019s change resulted from a four-year review released Tuesday evening by Dr. Hilary Cass, an independent pediatrician. \u201cFor most young people, a medical pathway will not be the best way to manage their gender-related distress,\u201d the report concluded. In a related editorial published in a medical journal, Dr. Cass said the evidence that youth gender treatments were beneficial was \u201cbuilt on shaky foundations.\u201dThe N.H.S. will no longer offer drugs that block puberty, except for patients enrolled in clinical research. And the report recommended that hormones like testosterone and estrogen, which spur permanent physical changes, be prescribed to minors with \u201cextreme caution.\u201d (The guidelines do not apply to doctors in private practice, who serve a small fraction of the population.)England\u2019s move is part of a broader shift in northern Europe, where health officials have been concerned by soaring demand for adolescent gender treatments in recent years. Many patients also have mental health conditions that make it difficult to pinpoint the root cause of their distress, known as dysphoria.In 2020, Finland\u2019s health agency restricted the care by recommending psychotherapy as the primary treatment for adolescents with gender dysphoria. Two years later, Sweden restricted hormone treatments to \u201cexceptional cases.\u201dIn December, regional health authorities in Norway designated youth gender medicine as a \u201ctreatment under trial,\u201d meaning hormones will be prescribed only to adolescents in clinical trials. And in Denmark, new guidelines being finalized this year will limit hormone treatments to transgender adolescents who have experienced dysphoria since early childhood.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into\u00a0your Times account, or\u00a0subscribe\u00a0for all of The Times.Thank you for your patience while we verify access.Already a subscriber?\u00a0Log in.Want all of The Times?\u00a0Subscribe.<\/p>\n","protected":false},"author":1,"featured_media":3792,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-3790","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lifestyle"],"_links":{"self":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/3790","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3790"}],"version-history":[{"count":2,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/3790\/revisions"}],"predecessor-version":[{"id":3793,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/3790\/revisions\/3793"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/media\/3792"}],"wp:attachment":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3790"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3790"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3790"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}